P H Yu, C T Lai, A A Boulton. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antiparkinson Agents/adverse effectsDopamine/metabolismDose-Response Relationship, DrugDrug Therapy, CombinationHumansLevodopa/adverse effectsParkinson Disease/drug therapyParkinson Disease/metabolismParkinson Disease/mortalitySelegiline/adverse effects
Substances: See more » Antiparkinson AgentsSelegilineLevodopaDopamine
Year: 1996 PMID: 8597749 PMCID: PMC2350556 DOI: 10.1136/bmj.312.7032.703b
Source DB: PubMed Journal: BMJ ISSN: 0959-8138